Gilead Sciences Sweden AB
Discovering and delivering transformative therapies for life-threatening diseases globally.
Yleiskatsaus
- 50–99
- Työntekijät
- 500–1000milj SEK
- Liikevaihto
- 2007
- Perustettu
Avainpäättäjät
Ashleigh Koss
Head of Global Media Relations
Elizabeth Baxter
Deputy Head of Media Relations
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing
Dietmar Berger, MD, PhD
Chief Medical Officer
+25 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Gilead Sciences is a leading biopharmaceutical company dedicated to discovering, developing, and delivering innovative therapeutics for people with life-threatening diseases. The organization focuses its world-class science across three primary therapeutic areas: Virology, Oncology, and Inflammation...